The combination of TDP-43 with the aforementioned AD biomarkers in the formula TDP-43 × τΤ/τP-181 may increase sensitivity and specificity (>80%) [18], while the τP-181/τT ratio has been proposed as an indirect indicator of a non-tauopathic pathology [22,23]. This evidence concerns the gene TARDBP and Alzheimer disease.